Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. - Wikidata - awgldk - TriplyDB

Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.

Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.

http://www.wikidata.org/entity/Q33832289

about

Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production Monocytes as regulators of inflammation and HIV-related comorbidities during cART Effects of dimethyl prostaglandin A1 on herpes simplex virus and human immunodeficiency virus replication HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4 Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection.The effects of HIV infection on endothelial function.Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro.Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes Interactions between major histocompatibility complex class II surface expression and HIV: implications for pathogenesis.COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection.The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.Human immunodeficiency virus type 1 envelope protein does not stimulate either prostaglandin formation or the expression of prostaglandin H synthase in THP-1 human monocytes/macrophages.Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection Interferon alpha (IFN)-macrophage interactions in human immunodeficiency virus (HIV) infection: role of IFN in the tempo and progression of HIV disease.Poxvirus-induced alteration of arachidonate metabolism.Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures.Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome.Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease Immunopathogenesis of HIV encephalitis.Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes.Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users.Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells.T-cell-induced expression of human immunodeficiency virus in macrophages Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.Monokine-mediated increase in human immunodeficiency virus type 1 expression in chronically infected promonocyte- and T-cell-derived lines Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120.HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.

P2860

Q24651506-8F4049F8-087C-4DA4-80E0-C061D5858564 Q24676612-1BD177DB-0481-444B-9E91-695377131FED Q24681688-F41AF4F7-EEE6-4027-875D-A5384B0E70BF Q24682179-DC0A0E17-2B7D-4555-A19F-864F118C0D79 Q27006827-5B76BE06-6717-4C8F-BF09-FF6AE276BF98 Q28327007-13385121-007A-42D0-965D-C1A556047EA8 Q28363800-66D80D18-3E07-458D-9EE1-5DB334C886F8 Q28365981-11CCDE76-8C05-45EC-91C2-E4C62E36724F Q28645865-25C3613F-5C3F-448E-A3EE-F5B8F6716F4E Q33572329-66E3ED05-7B21-4223-983C-9EE2650822E9 Q33864034-C5034CB8-CFFC-4FFE-9404-68F10DCDF421 Q34153342-E6A2747F-A23E-4206-9F94-6DFAD383461B Q34240496-CE655AE7-5C8D-4571-B884-C86BA8A93404 Q34255757-803547BC-E975-4A79-893C-62F9846F6402 Q34459242-66F6F89E-37C7-494E-B638-4D3D0F88F8DA Q34732834-291ADF11-094D-457C-87AD-A3A3AC089FF4 Q34789326-40C46904-044E-4237-9491-05B004E13C07 Q35066362-075518FE-5016-4894-9165-C22B63160968 Q35852581-C724F789-51C6-4270-8C4A-E1CB170FB33D Q35862050-EEBB9FBE-E4AA-492E-B530-22DC917B79D5 Q35975337-6690B7A7-759B-401F-B528-B223CE78ABD4 Q36055546-C6E955E1-B56F-49FE-A50D-29511A29E2AB Q36147156-BEE7A623-49B7-4B0D-8BBF-386ADFF56653 Q36232123-8430DBF9-732A-44B3-A35F-D189B8710DBF Q36233456-3B2F6481-32DF-4E0D-861C-BC760416CB66 Q36360983-03BA311C-6E9E-4674-9828-870AFA9DCD0E Q36364798-CCFD5F0A-7A8C-4C67-BF07-C1D02B30AED5 Q36476942-97E8D2DE-2F54-4338-8608-E1F27E657FBB Q36623039-F7DC40FA-2030-469E-A8F1-E63B7B228D4E Q36687077-1A2934BA-C048-4F7D-AECD-95DE782673C5 Q36698842-6FE3E12C-9CD7-4E16-816C-E9B968502398 Q36716624-2017C787-FB74-4730-A8DF-6FC1CE530045 Q36807813-B1924DE1-CFE9-4FDD-B445-C04456FC12DE Q36809884-197907D6-E4A9-4E0F-8FC0-B15ACA86136A Q36831191-1950BE69-C305-44A6-9C28-8913D72DA139 Q36930865-6BA77C50-A8A9-4CC8-84CC-C43B7B8CDC20 Q37279360-39C55506-0F71-4191-A4CD-3A7D675795DB Q37368552-28CC59EC-1AAC-42F2-BD22-43C4477712F0 Q37372518-DAE1A246-3B27-4152-A8E6-1CDCA36BB32F Q37384536-BAECB46B-4FB4-41ED-A217-C14731DF2C7E

P2860

Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.

http://www.wikidata.org/entity/Q33832289

description

1989 nî lūn-bûn

@nan

1989 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Human immunodeficiency virus g ...... metabolites and interleukin 1.

@ast

Human immunodeficiency virus g ...... metabolites and interleukin 1.

@en

type

label

Human immunodeficiency virus g ...... metabolites and interleukin 1.

@ast

Human immunodeficiency virus g ...... metabolites and interleukin 1.

@en

prefLabel

Human immunodeficiency virus g ...... metabolites and interleukin 1.

@ast

Human immunodeficiency virus g ...... metabolites and interleukin 1.

@en

P1433

Q33832289-7C1F8D9A-2D8B-452B-83E0-5816191E7E6B

P1476

Q33832289-EA1EB24D-EF1F-4DC1-95C2-C8800467E81C

P2093

Q33832289-07917D77-40EF-416A-A553-86D4C7D4CB2A

Q33832289-08D1464D-0E86-409E-A460-6D407A6251C5

Q33832289-357798E0-E09A-406E-9408-66110E7178F7

Q33832289-5C9CFA52-8E9B-4DAB-973B-E925BED7E23A

Q33832289-8E8467BB-1050-4C73-96BD-86CD8E84E034

Q33832289-E3DCD195-630A-4C64-92E5-D1349B52B99E

P2860

Q33832289-0224F423-653F-44CD-8CDE-A1915A7D837A

Q33832289-127A8630-1546-47E8-90E4-A3228D1FDE68

Q33832289-177F151A-D260-41A1-B200-95FB58601D39

Q33832289-17CFA9F5-8792-4E08-AB70-DAD3133EE730

Q33832289-24470652-B3DB-461B-A57F-FE51259EE972

Q33832289-2EAEF025-EADA-4A4C-8A47-28E5DFAAA4FC

Q33832289-34A1EB2B-07D2-441D-B68E-C83D0493BE0E

Q33832289-40EB55C1-0CCD-43BD-A1F2-DCB80B6B874C

Q33832289-419EA3A9-F91A-4D25-8EA5-FC147E841AE6

Q33832289-54018F1D-B2EA-4832-A074-F2CC72002EDC

P304

Q33832289-BD866EF0-AF86-47BE-AB08-C5D0F688A971

P31

Q33832289-56B951BC-9764-4DE8-AD02-AC816F8B625E

P356

Q33832289-59E107C1-E644-4614-85CF-AEDC33CBE27D

P407

Q33832289-F065BBBF-D27A-4E44-8F20-F085BFB4FCB0

P433

Q33832289-E9A1B107-0B39-46BB-B50E-EEBC1AA190E1

P478

Q33832289-5DE3EB10-C494-4B7B-843E-838B8E097678

P577

Q33832289-67AC838E-6035-4DD6-912E-C85F8BE1D64D

P5875

Q33832289-E1E2A8C4-8BDA-403E-BDC6-0D16F79F5CDB

P698

Q33832289-2859C32F-8CBF-4F73-BCFB-32FE14FAB9E4

P932

Q33832289-6D1D6236-9884-429D-B46B-150CC5073F11

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Human immunodeficiency virus g ...... metabolites and interleukin 1.

@en

P2093

A Harel-Bellan

http://www.w3.org/2001/XMLSchema#string

L M Wahl

http://www.w3.org/2001/XMLSchema#string

L O Arthur

http://www.w3.org/2001/XMLSchema#string

M L Corcoran

http://www.w3.org/2001/XMLSchema#string

S W Pyle

http://www.w3.org/2001/XMLSchema#string

W L Farrar

http://www.w3.org/2001/XMLSchema#string

P2860

Complete nucleotide sequence of the AIDS virus, HTLV-III

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule

Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

The role of mononuclear phagocytes in HTLV-III/LAV infection

Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Control of polyclonal immunoglobulin production from human lymphocytes by leukotrienes; leukotriene B4 induces an OKT8(+), radiosensitive suppressor cell from resting, human OKT8(-) T cells.

Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses.

P304

621-625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.86.2.621

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

1989-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20620322

http://www.w3.org/2001/XMLSchema#string

P698

2536171

http://www.w3.org/2001/XMLSchema#string

P932

286524

http://www.w3.org/2001/XMLSchema#string